APA
Kopylov U., Verstockt B., Biedermann L., Sebastian S., Pugliese D., Sonnenberg E., Steinhagen P., Arebi N., Ron Y., Kucharzik T., Roblin X., Ungar B., Shitrit A. B., Ardizzone S., Molander P., Coletta M., Peyrin-Biroulet L., Bossuyt P., Avni-Biron I., Tsoukali E., Allocca M., Katsanos K., Raine T., Sipponen T., Fiorino G., Ben-Horin S., Eliakim R., Armuzzi A., Siegmund B., Baumgart D. C., Kamperidis N., Maharshak N., Maaser C., Mantzaris G., Yanai H., Christodoulou D. K., Dotan I. & Ferrante M. (20190830). Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study. : Inflammatory bowel diseases.
Chicago
Kopylov Uri, Verstockt Bram, Biedermann Luc, Sebastian Shaji, Pugliese Daniela, Sonnenberg Elena, Steinhagen Peter, Arebi Naila, Ron Yulia, Kucharzik Torsten, Roblin Xavier, Ungar Bella, Shitrit Ariella Bar-Gil, Ardizzone Sandro, Molander Pauliina, Coletta Marina, Peyrin-Biroulet Laurent, Bossuyt Peter, Avni-Biron Irit, Tsoukali Emmanouela, Allocca Mariangela, Katsanos Konstantinos, Raine Tim, Sipponen Taina, Fiorino Gionata, Ben-Horin Shomron, Eliakim Rami, Armuzzi Alessandro, Siegmund Britta, Baumgart Daniel C, Kamperidis Nikolaos, Maharshak Nitsan, Maaser Christian, Mantzaris Gerassimos, Yanai Henit, Christodoulou Dimitrious K, Dotan Iris and Ferrante Marc. 20190830. Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study. : Inflammatory bowel diseases.
Harvard
Kopylov U., Verstockt B., Biedermann L., Sebastian S., Pugliese D., Sonnenberg E., Steinhagen P., Arebi N., Ron Y., Kucharzik T., Roblin X., Ungar B., Shitrit A. B., Ardizzone S., Molander P., Coletta M., Peyrin-Biroulet L., Bossuyt P., Avni-Biron I., Tsoukali E., Allocca M., Katsanos K., Raine T., Sipponen T., Fiorino G., Ben-Horin S., Eliakim R., Armuzzi A., Siegmund B., Baumgart D. C., Kamperidis N., Maharshak N., Maaser C., Mantzaris G., Yanai H., Christodoulou D. K., Dotan I. and Ferrante M. (20190830). Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study. : Inflammatory bowel diseases.
MLA
Kopylov Uri, Verstockt Bram, Biedermann Luc, Sebastian Shaji, Pugliese Daniela, Sonnenberg Elena, Steinhagen Peter, Arebi Naila, Ron Yulia, Kucharzik Torsten, Roblin Xavier, Ungar Bella, Shitrit Ariella Bar-Gil, Ardizzone Sandro, Molander Pauliina, Coletta Marina, Peyrin-Biroulet Laurent, Bossuyt Peter, Avni-Biron Irit, Tsoukali Emmanouela, Allocca Mariangela, Katsanos Konstantinos, Raine Tim, Sipponen Taina, Fiorino Gionata, Ben-Horin Shomron, Eliakim Rami, Armuzzi Alessandro, Siegmund Britta, Baumgart Daniel C, Kamperidis Nikolaos, Maharshak Nitsan, Maaser Christian, Mantzaris Gerassimos, Yanai Henit, Christodoulou Dimitrious K, Dotan Iris and Ferrante Marc. Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study. : Inflammatory bowel diseases. 20190830.